This may include ads from us and 3 rd parties based on our understanding. The globally available drug heparin is found to lower the risk of death in moderately ill patients, according to a new study. Researchers at St Michael's Hospital have tested a low, high dose of the drug against a prophylactic high dose. The drug was tested against patients admitted with COVID - 19 who showed increased d-dimer levels produced when blood clots dissolve in the body.
Higher levels of d-dimers indicate a higher risk for blood clot formation. Heparin is a popular blood thinner used to prevent the formation of clots in blood vessels. The St Michael researchers studied a total of 465 patients across 28 hospitals in Brazil, Canada, Ireland, Saudi Arabia, United Arab Emirates and the US. All patients were admitted to hospitals between May 29, 2020 and April 12, 2021 and were randomly assigned one of two doses of heparin. NASA: Alien Life breakthrough as NASA spots persistent water on Europa?